Literature DB >> 21880530

Hematological abnormalities in HIV-infected patients.

Gil Cunha De Santis1, Denise Menezes Brunetta, Fernando Crivelenti Vilar, Renata Amorim Brandão, Renata Zomer de Albernaz Muniz, Geovana Momo Nogueira de Lima, Manuela Emiliana Amorelli-Chacel, Dimas Tadeu Covas, Alcyone Artioli Machado.   

Abstract

BACKGROUND: Anemia, neutropenia, and thrombocytopenia are commonly observed in HIV-infected patients. This study was undertaken to evaluate the prevalence of cytopenias and their association with CD4 count. Furthermore, the association of hemoglobin concentration with mortality was also investigated.
METHODS: We reviewed the data of 701 HIV-infected patients followed at our institution. Blood cell counts, hemoglobin concentration, CD4 count, and viral load were recorded. We also recorded the mortality rate after 1 year in the groups with CD4 <200/μl and ≥ 200/μl according to hemoglobin concentration.
RESULTS: Of the total patients, 37.5% had anemia; 61.1% (110/180) were in the low CD4 group and 29.4% (153/521) were in the high CD4 group (p<0.01). Mean neutrophil counts were 2.610 × 10(9)/l and 3.204 × 10(9)/l in the low CD4 and high CD4 groups, respectively (p<0.01); mean platelet counts were 218.639 × 10(9)/l and 234.807 × 10(9)/l for the low CD4 and the high CD4 groups, respectively (p=0.03). Patients whose hemoglobin concentration was below the median value had a higher death rate in both the low CD4 (14 vs. 4 deaths, p=0.013) and high CD4 (8 vs. 1 death, p=0.0158) groups.
CONCLUSIONS: We found an association between CD4 count and hemoglobin level, neutrophil count, and platelet count, and that anemia was independently associated with a higher mortality.
Copyright © 2011 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21880530     DOI: 10.1016/j.ijid.2011.08.001

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  40 in total

1.  Assessment of two POC technologies for CD4 count in Morocco.

Authors:  Elmir Elharti; Halima Abbadi; Rajae Bensghir; Kamal Marhoum El Filali; Hajar Elmrabet; Hicham Oumzil
Journal:  AIDS Res Ther       Date:  2020-06-10       Impact factor: 2.250

2.  Depression Correlates with Increased Plasma Levels of Inflammatory Cytokines and a Dysregulated Oxidant/Antioxidant Balance in HIV-1-Infected Subjects Undergoing Antiretroviral Therapy.

Authors:  Yainyrette Rivera-Rivera; Yashira García; Valerie Toro; Nydia Cappas; Pablo López; Yasuhiro Yamamura; Vanessa Rivera-Amill
Journal:  J Clin Cell Immunol       Date:  2014-12

3.  Immuno-Haematological Abnormalities of HIV-Infected Patients Before and After Initiation of Highly Active Antiretroviral Therapy in the Antiretroviral Therapy Clinics of Six Health Facilities at Dessie Town, Northeast Ethiopia.

Authors:  Mihret Tilahun; Alemu Gedefie; Endris Ebrahim; Abdurahaman Seid; Abdurrahman Ali; Agumas Shibabaw; Melaku Ashagrie Belete; Mesfin Fiseha; Melkam Tesfaye; Hussen Ebrahim; Admasu Abera
Journal:  J Blood Med       Date:  2022-05-11

4.  Factors Associated with Baseline CD4 Cell Counts and Advanced HIV Disease among Male and Female HIV-Positive Patients in Iran: A Retrospective Cohort Study.

Authors:  Sima Afrashteh; Mohammad Fararouei; Haleh Ghaem; Mohammad Aryaie
Journal:  J Trop Med       Date:  2022-07-07

5.  Hematologic, hepatic, renal, and lipid laboratory monitoring after initiation of combination antiretroviral therapy in the United States, 2000-2010.

Authors:  Elizabeth L Yanik; Sonia Napravnik; Patrick Ryscavage; Joseph J Eron; Susan L Koletar; Richard D Moore; Anne Zinski; Stephen R Cole; Peter Hunt; Heidi M Crane; James Kahn; William C Mathews; Kenneth H Mayer; Babafemi O Taiwo
Journal:  J Acquir Immune Defic Syndr       Date:  2013-06-01       Impact factor: 3.731

6.  Predictive value of anemia for tuberculosis in HIV-infected patients in Sub-Saharan Africa: an indication for routine microbiological investigation using new rapid assays.

Authors:  Andrew D Kerkhoff; Robin Wood; Monica Vogt; Stephen D Lawn
Journal:  J Acquir Immune Defic Syndr       Date:  2014-05-01       Impact factor: 3.731

7.  Assessment of Maternal and Fetal Dolutegravir Exposure by Integrating Ex Vivo Placental Perfusion Data and Physiologically-Based Pharmacokinetic Modeling.

Authors:  Jolien J M Freriksen; Stein Schalkwijk; Angela P Colbers; Khaled Abduljalil; Frans G M Russel; David M Burger; Rick Greupink
Journal:  Clin Pharmacol Ther       Date:  2020-01-24       Impact factor: 6.875

8.  Predictors of Anemia Among Adult HIV Positive Patients on First-Line Antiretroviral Therapy in Northwest Ethiopia: A Retrospective Follow-Up Study.

Authors:  Chilot Desta Agegnehu; Mehari Woldemariam Merid; Melaku Kindie Yenit
Journal:  HIV AIDS (Auckl)       Date:  2021-04-29

Review 9.  Current practices in laboratory monitoring of HIV infection.

Authors:  Madhu Vajpayee; Teena Mohan
Journal:  Indian J Med Res       Date:  2011-12       Impact factor: 2.375

10.  Anemia among Patients Attending Anti-retroviral Therapy at a Tertiary Care Center: A Descriptive Cross-sectional Study.

Authors:  Bibhant Shah; Lochan Karki; Rajesh Kumar Mandal
Journal:  JNMA J Nepal Med Assoc       Date:  2021-12-11       Impact factor: 0.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.